The study is intended to focus on diagnostics and treatment of Lyme IACI symptoms and not to improve diagnostics and treatment for acute Lyme disease. As such, the prevention of Lyme disease ...

Your skin may burn more easily during treatment and for several months after. Depending on the treatments you have had, you may have a higher risk of developing some types of skin cancer. Your cancer ...

In fact, treatment might need to be started even if the diagnosis of APL is suspected but hasn't been confirmed yet by lab tests. APL treatment differs from the treatment of most other types of AML.

Alys Pharmaceuticals announces CTA submission for ALY-301, the first mast cell selective c-Kit inhibitor for treatment of Cold Urticaria. Tuesday, June 10, 2025 Drug News. Advertisement ...

Alys Pharmaceuticals, Inc. ("Alys"), an immune-dermatology focused company, today announces the submission of a Clinical Trial Application (CTA) to Germany's Paul-Ehrlich-Institut (PEI) to initiate a ...

ALY-301 is the first mast cell-selective c-Kit inhibitor to enter the clinic. It is a cis-targeting bispecific antibody binding c-Kit and CD-203c, allowing selective targeting and depletion of ...

Alys Pharmaceuticals announces CTA submission for ALY-301, the first mast cell selective c-Kit inhibitor for treatment of Cold Urticaria By Alys Pharmaceuticals Jun 10, 2025 ...

Manchester United's third kit for the 2025/2026 season has been leaked online ahead of the new campaign.